Boston biotech company Pepper Bio is on a mission to develop cures for untreatable diseases using machine learning. Their primary objective is to enhance and accelerate drug discovery by applying insights from their revolutionary transomics platform.
Backed by global pharma giant Merck, this brilliant innovation has the potential to save countless lives. However, progress was hindered by the lengthy conversations and onboarding needed to explain their groundbreaking approach to prospective partners with varying levels of scientific knowledge.
Partnering in the crucial early stages of their startup journey, we worked together to present their technology and its value in the most persuasive, easily understandable way — giving Pepper Bio the tools they needed to open doors and gain traction.
After quickly getting to grips with the subject, we combined user-centred design and carefully considered messaging to translate what we learned into an engaging story that can flex to reach diverse audiences effectively.
We're proud to continue our partnership as Pepper Bio goes from strength to strength, reaching new audiences worldwide.
The Luna 9 team took the time to walk through our technology and help us develop a strategy to present it in the clearest and most engaging way possible. They were thoughtful, creative, and fun to work with throughout the process.
Caitlin Brown, Head of Business Development, Pepper
Just two brief meetings and you were able to go away and create something that surpassed our expectations. It was so impressive.
Dr Chris Nicholson, Head of Biology
Pepper
The key here was not dumbing down the complex technology but giving it context and clarity so that its impact landed with those outside the deep science bubble.
Michael Green, Strategy Director
Luna 9
